【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Highlights
PART 05: Global pharmaceutical market
• Market size and forecast
PART 06: Road to pharmerging markets
PART 07: Pharmerging markets
PART 08: Market landscape
• Medicine spending in emerging economies
• Five forces analysis
PART 09: Market segmentation by geography
PART 10: Market overview of tier I countries
• China
PART 11: Market overview of tier II countries
• Brazil
• Russia
• India
PART 12: Market overview of tier III countries
• Market size and forecast
PART 13: Market drivers
• Limitations in developed economies fuels demand in emerging economies
• Increasing focus toward biosimilar in potential areas
• Expansion initiatives of vendors
PART 14: Impact of drivers
PART 15: Market challenges
• IP protection issues
• Socio-political issues in cross geography transactions
• Stringent price control and generic-centric usage lead to value erosion
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Potential of new countries in emerging markets
• Positive outlook toward adoption of targeted therapies
• Evolving stakeholder landscape to change market dynamics
PART 18: Vendor landscape
• Competitive scenario
PART 19: Key vendor analysis
• AstraZeneca
• GlaxoSmithKline
• Pfizer
• Sanofi
• Novartis
• Other prominent vendors
PART 20: Appendix
• List of Abbreviations
PART 21: Explore Technavio
[List of Exhibits]
Exhibit 01: Global country rankings in pharmaceutical market based on healthcare spending
Exhibit 02: Global pharmaceutical market 2016-2021 ($ trillions)
Exhibit 03: Drivers, challenges and trends of global pharmaceutical market
Exhibit 04: Growth comparision between developed markets and pharmerging markets
Exhibit 05: Share of pharmerging markets in global pharmaceutical market, 2016
Exhibit 06: Snapshot of key pharmerging markets
Exhibit 07: Regulatory landscape in key pharmerging markets
Exhibit 08: Pharmerging markets 2016-2021 ($ billions)
Exhibit 09: Comparison of medicine spending in developed economies and pharmerging markets
Exhibit 10: Medicine spending and growth rates in pharmerging markets
Exhibit 11: Standard units in 2021 by product type in pharmerging countries
Exhibit 12: Expected medicine spending by geography
Exhibit 13: Volume growth and population with more than $5,000/year income by country 2016
Exhibit 14: Percentage share of pharmerging markets in global pharmaceutical market 2016-2021
Exhibit 15: Percentage share of tier I, II and III countries in total pharmerging markets 2016-2021
Exhibit 16: Pharmerging markets share by country, 2016
Exhibit 17: Five forces analysis
Exhibit 18: Pharmerging markets segment by geography
Exhibit 19: Geographic representation of tier I country
Exhibit 20: China GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 21: On-going healthcare reforms in China
Exhibit 22: Segmentation of Chinese pharmaceutical market
Exhibit 23: Segment analysis in Chinese pharmaceutical market
Exhibit 24: Regulatory bodies
Exhibit 25: Major therapy areas based on sales of drugs, 2016
Exhibit 26: Major acquisitions in Chinese pharmaceutical market 2014-2016
Exhibit 27: Drivers and challenges in Chinese pharmaceutical market
Exhibit 28: Pharmaceutical market in China 2016-2021 ($ billions)
Exhibit 29: China pharmaceutical market: SWOT analysis
Exhibit 30: Geographic representation of tier II countries
Exhibit 31: Pharmaceutical market in tier II countries 2016-2021 ($ billions)
Exhibit 32: Brazil GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 33: Regulatory bodies
Exhibit 34: Segmentation of pharmaceutical market in Brazil 2016
Exhibit 35: Major acquisitions in Brazil pharmaceutical market
Exhibit 36: Drivers and challenges in Brazilian pharmaceutical market
Exhibit 37: Pharmaceutical market in Brazil 2016-2021 ($ billions)
Exhibit 38: Brazil pharmaceutical market: SWOT analysis
Exhibit 39: Russia GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 40: Major acquisitions in Russian pharmaceutical market
Exhibit 41: Drivers and challenges in Russian pharmaceutical market
Exhibit 42: Pharmaceutical market in Russia 2016-2021 ($ billions)
Exhibit 43: Russia pharmaceutical market: SWOT analysis
Exhibit 44: India GDP 2011-2015 ($ trillions) and healthcare expenditure 2010-2014 (% of GDP)
Exhibit 45: Regulatory landscape
Exhibit 46: Major acquisitions in pharmaceutical sector in India
Exhibit 47: Drivers and challenges in Indian pharmaceutical market
Exhibit 48: Pharmaceutical market in India 2016-2021 ($ billions)
Exhibit 49: India pharmaceutical market: SWOT analysis
Exhibit 50: Geographic representation of tier III countries
Exhibit 51: Pharmaceutical market in tier III countries 2016-2021 ($ billions)
Exhibit 52: Revenues from pharmaceuticals for few of the tier III countries 2016 ($ billions)
Exhibit 53: Snapshot of key countries in tier III countries
Exhibit 54: Tier III countries pharmaceutical market: SWOT analysis
Exhibit 55: Factors that are driving the growth in emerging economies
Exhibit 56: Biosimilar development in emerging economies
Exhibit 57: Few acquisitions and their impact
Exhibit 58: Impact of drivers
Exhibit 59: Impact of drivers and challenges
Exhibit 60: Positioning of key vendors in pharmerging markets 2015
Exhibit 61: Competitive analysis snapshot
Exhibit 62: Top selling products in emerging markets 2015
Exhibit 63: Key takeaways
Exhibit 64: Key highlights in emerging markets
Exhibit 65: AstraZeneca strength assessment
Exhibit 66: Geographic segmentation by revenue 2015
Exhibit 67: Key takeaways
Exhibit 68: Key highlights in emerging markets
Exhibit 69: GSK strength assessment
Exhibit 70: Geographic segmentation by revenue 2015
Exhibit 71: Key takeaways
Exhibit 72: Pfizer: YoY and growth rate in emerging markets
Exhibit 73: Segmentation by revenue in emerging markets ($ millions)
Exhibit 74: Key highlights in emerging markets
Exhibit 75: Pfizer strength assessment
Exhibit 76: Pfizer: Geographical segmentation by revenue 2015
Exhibit 77: Top selling products0
Exhibit 78: Key emerging products0
Exhibit 79: Geographical segmentation by revenue1
Exhibit 80: Key takeaways2
Exhibit 81: Key highlights in emerging markets2
Exhibit 82: Sanofi strength assessment3
Exhibit 83: Key takeaways4
Exhibit 84: Key highlights in emerging markets5
Exhibit 85: Novartis strength assessment6
Exhibit 86: Novartis: Geographical segmentation by revenue 20156
【レポート販売概要】
■ タイトル：医薬品新興国市場2017-2021■ 英文：Global Pharmerging Markets 2017-2021
■ 発行日：2017年1月16日
■ 調査会社：Technavio
■ 商品コード：IRTNTR11577
■ 調査対象地域：ブラジル、ロシア、中国、インド、トルコ、メキシコ、韓国
- 事業提携・ライセンシング・投資・M&A動向：August 2013（製薬業界）Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provide …
- 電子出版の世界市場：STM（科学/技術/医学）、法律、ビジネスAbout digital publishing Over the past decade, digitization has brought about a paradigm shift in the traditional publishing industry. Publishing and information companies are transitioning from print-based media to digital media, providing content, software, and services. Spurred by the evolution of a supportive infrastructure and a networked environment, the market is witnessing the creation of …
- 通信試験及び測定ソリューションの世界市場MarketsandMarkets forecast the Communication Test and Measurement market size to grow from USD 4.28 Billion in 2015 to USD 6.69 Billion by 2020, at a compound annual growth rate (CAGR) of 9.3% from 2015 to 2020. The growing network traffic and need for test and measurement equipment is driving the market across all regions. The growing demand for automated products and increasing telecommunication …
- ノルウェーの発電市場2016：市場動向、制度、競争状況Norway Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Norway's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Norway power market’s regulatory structure, import and export trends, competitive landscape, and power projec …
- 世界の整形外科用軟部組織修復装置市場（2014-2018）About Orthopedic Soft Tissue Repair Devices Orthopedic soft tissues are the mass of cells that connect, support, or surround bones. There are several types of orthopedic soft tissues such as tendons, ligaments, cartilage, fascia, and other fibrous tissues. Repetitive use, accidents, injuries, and the degeneration of these tissues with age result in wear and tear in these tissues. Orthopedic soft t …
- ベータグルカン市場動向Product Synopsis This forecast report on Beta-Glucans covers an in-depth analysis of Beta-Glucan ingredients manufacturers and ingredients characteristics in relation to raw material use and extraction methods. The report investigates health benefits of Beta-Glucans and their regulatory status. The use for this ingredient category for food and beverage products is discussed and product case storie …
- バックアップ電源の世界市場ABSTRACTAbout Backup Power Power outages can be caused due to natural calamities, overload, or equipment failures. It is a recurring problem that disrupts the operations in residential, commercial, and industrial sectors. The monetary losses incurred vary from sector to sector and can run into millions. Therefore, to minimize the losses and stay protected against utility power outages, backup powe …
- プロゲステロンの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Progesterone testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratorie …
- カプセル内視鏡の世界市場：小腸検査、食道検査、結腸検査About Capsule Endoscopy Capsule endoscopy is a modern technique used to examine the gastrointestinal tract. Wireless capsule endoscopy is a novel breakthrough in the biomedical industry and is expected to drive the development of the next-generation medical devices in the field of endoscopy. It has a tiny wireless camera to capture pictures of the digestive tract of a patient. The camera is situat …
- FRP（ガラス繊維強化プラスチック）筋の世界市場予測（～2021）The global market size of FRP rebars, in terms of value, is projected to reach USD 91.00 Million by 2021, at a CAGR of 11.4% between 2016 and 2021. The increasing number of patents filed for FRP rebars products & applications by global players, growing projects, continuous agreements, and expansion activities undertaken by companies are key factors for the growth of the global market for FRP rebar …
- インダストリアル・インターネットの世界市場：M2M、スマートデバイス、ビックデータ分析、IoTの将来The Industrial Internet market is set for accelerated growth in 2015 as more businesses realize its potential uses and the positive impact it can have upon various industry verticals. The Industrial Internet market has already gained momentum with increasing adoption, offering a wide variety of uses and portfolio of applications, which is expanding sizeably. The main attraction offered by the Indu …
- 整形外科手術用パワーツールの世界市場2016-2020About Orthopedic Surgical Power Tools Orthopedic surgical power tools are specially designed devices that carry out a specific action such as drilling and fixing implants during surgeries. Surgical power tools such as drills, saws, and reamers use different power sources for their operation. Power source can be electric, battery-driven, or pneumatic, which means compressed gases such as nitrogen o …
- 大規模公開オンライン講座（MOOC）の世界市場：xMOOC、cMOOCThe MOOC’s market is exhibiting great potential to grow exponentially over the next few years. In 2015, the technology is poised to see substantial uptake due to the growing number of connected devices, high enrolment rates in MOOCs, the increasing acceptance of MOOCs based training in enterprises around the globe and the increasing demand for low cost, high quality and globalised education. Consu …
- クラウドコンピューティング市場分析：機会、課題、展望Software is more essential in the cloud computing than hardware, Software as a service (SaaS) refers to software in the cloud. SaaS is a web-based application which makes the software entirely available through the web-browser. Cloud computing will change the way enterprises do IT business, and it will mobilize the software anywhere at any time. Users will not have to worry about premise related i …
- 歯科用バイオマテリアルの世界市場予測（～2023年）“The dental biomaterials market is projected to grow at a CAGR of 7.4%.”The global dental biomaterials market is projected to reach USD 9.6 billion by 2023, from USD 6.7 billion in 2018 growing at a CAGR of 7.4% from 2018 to 2023. Factors such as the increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable inc …
